121 related articles for article (PubMed ID: 22919996)
1. Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2012 Mar; 51(1):3-7. PubMed ID: 22919996
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
[TBL] [Abstract][Full Text] [Related]
3. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
[TBL] [Abstract][Full Text] [Related]
4. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
[TBL] [Abstract][Full Text] [Related]
5. Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Clin Biochem; 2011 Jun; 44(8-9):650-3. PubMed ID: 21349256
[TBL] [Abstract][Full Text] [Related]
6. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
8. High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
Sawada R; Arai Y; Sagawa Y; Nagata Y; Nishimura T; Noguchi M; Amano K; Arihiro S; Saruta M; Homma S
Oncol Rep; 2019 Nov; 42(5):2057-2064. PubMed ID: 31545443
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
10. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
[TBL] [Abstract][Full Text] [Related]
11. The role of soluble intercellular adhesion molecules in neurodegenerative disorders.
Rentzos M; Michalopoulou M; Nikolaou C; Cambouri C; Rombos A; Dimitrakopoulos A; Vassilopoulos D
J Neurol Sci; 2005 Feb; 228(2):129-35. PubMed ID: 15694193
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble intercellular adhesion molecule-1 (s-ICAM-1) and soluble endothelial leukocyte adhesion molecule-1(s-ELAM-1) in amyotrophic lateral sclerosis.
Rentzos M; Michalopoulou M; Nikolaou C; Rombos A; Dimitrakopoulos A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):118-21. PubMed ID: 16036437
[TBL] [Abstract][Full Text] [Related]
13. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
16. Identification of a soluble OX40 isoform: development of a specific and quantitative immunoassay.
Taylor L; Schwarz H
J Immunol Methods; 2001 Sep; 255(1-2):67-72. PubMed ID: 11470287
[TBL] [Abstract][Full Text] [Related]
17. Increased serum soluble OX40 in patients with systemic sclerosis.
Komura K; Yoshizaki A; Kodera M; Iwata Y; Ogawa F; Shimizu K; Wayaku T; Yukami T; Murata M; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
[TBL] [Abstract][Full Text] [Related]
18. Association of high levels of plasma OX40 with acute adult T-cell leukemia.
Tanaka Y; Takahashi Y; Tanaka R; Miyagi T; Saito M; Fukushima T
Int J Hematol; 2019 Mar; 109(3):319-327. PubMed ID: 30652238
[TBL] [Abstract][Full Text] [Related]
19. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
